BACKGROUND: After hematopoietic stem cell transplantation (HSCT), early detection of engraftment would be of critical value for clinicians. The aim of this study was to identify faster parameters for engraftment. METHODS: We evaluated blood cell parameters including complete blood count (CBC), differential counts, and various reticulocyte parameters in 115 patients who received HSCT (allogeneic, n = 93; autologous, n = 22) in the purpose of identifying possible improved laboratory guidelines for engraftment prediction. RESULTS AND CONCLUSION: Days to white blood cell (WBC) count over 100 cells/μl with more than two-fold increase from nadir after transplantation (proposed new WBC guideline) preceded absolute neutrophil count (ANC) >500 cells/μl by 1.7 days. Among erythroid parameters, the earliest marker for erythroid engraftment was high light scattering reticulocytes (HLR) >0.1 (proposed new red blood cell guideline), which preceded reticulocyte counts (RET) >1% and immature reticulocyte fraction >0.5 by 3.9 and 1.6 days, respectively. Among the clinical parameters compared, those with statistically significant influence on myeloid engraftment were donor type (P = 0.009) and conditioning intensity (P = 0.009). As for erythroid recovery, ABO incompatibility was the only significant factor. In conclusion, the new guidelines may ensure engraftment several days earlier than the conventional parameters, which may help clinicians for decision-making on rescue therapy earlier.
BACKGROUND: After hematopoietic stem cell transplantation (HSCT), early detection of engraftment would be of critical value for clinicians. The aim of this study was to identify faster parameters for engraftment. METHODS: We evaluated blood cell parameters including complete blood count (CBC), differential counts, and various reticulocyte parameters in 115 patients who received HSCT (allogeneic, n = 93; autologous, n = 22) in the purpose of identifying possible improved laboratory guidelines for engraftment prediction. RESULTS AND CONCLUSION: Days to white blood cell (WBC) count over 100 cells/μl with more than two-fold increase from nadir after transplantation (proposed new WBC guideline) preceded absolute neutrophil count (ANC) >500 cells/μl by 1.7 days. Among erythroid parameters, the earliest marker for erythroid engraftment was high light scattering reticulocytes (HLR) >0.1 (proposed new red blood cell guideline), which preceded reticulocyte counts (RET) >1% and immature reticulocyte fraction >0.5 by 3.9 and 1.6 days, respectively. Among the clinical parameters compared, those with statistically significant influence on myeloid engraftment were donor type (P = 0.009) and conditioning intensity (P = 0.009). As for erythroid recovery, ABO incompatibility was the only significant factor. In conclusion, the new guidelines may ensure engraftment several days earlier than the conventional parameters, which may help clinicians for decision-making on rescue therapy earlier.
Authors: M L Grazziutti; L Dong; M H Miceli; M Cottler-Fox; S G Krishna; A Fassas; F van Rhee; B M Barlogie; E J Anaissie Journal: Bone Marrow Transplant Date: 2006-02 Impact factor: 5.483
Authors: Marjorie L Zucker; Carol A Murphy; Jane M Rachel; Gregory A Martinez; Sunil Abhyankar; Joseph P McGuirk; Kimberly J Reid; Fred V Plapp Journal: Lab Hematol Date: 2006
Authors: Grzegorz Helbig; Beata Stella-Holowiecka; Malgorzata Krawczyk-Kulis; Jerzy Wojnar; Miroslaw Markiewicz; Maria Wojciechowska-Sadus; Malgorzata Kopera; Tomasz Kruzel; Jacek Najda; Katarzyna Nowak; Jerzy Holowiecki Journal: Haematologica Date: 2005-11 Impact factor: 9.941
Authors: J Dubovsky; H Daxberger; G Fritsch; D Printz; C Peters; S Matthes; H Gadner; T Lion; N Muller-Bérat Journal: Leukemia Date: 1999-12 Impact factor: 11.528
Authors: V Pullarkat; S Blanchard; B Tegtmeier; A Dagis; K Patane; J Ito; S J Forman Journal: Bone Marrow Transplant Date: 2008-09-01 Impact factor: 5.483
Authors: Anuj Mahindra; Brian Bolwell; Ronald Sobecks; Lisa Rybicki; Brad Pohlman; Robert Dean; Steve Andresen; John Sweetenham; Matt Kalaycio; Edward Copelan Journal: Br J Haematol Date: 2009-06-08 Impact factor: 6.998